‘Ineffective’ Indian Price Controls Need Rethink: Study
This article was originally published in The Pink Sheet Daily
Executive Summary
A new study concludes that government-imposed drug price controls in India have mainly benefited the country’s well-off citizens and do not increase access to medicines for the vast poor population, recommending that measures to improve the situation could include boosting healthcare financing, extending universal health coverage and promoting bulk drug procurement.